Pendal Group’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | $85.4M | Buy |
118,417
+6,651
| +6% | +$4.8M | 0.74% | 50 |
|
|
2022
Q3 | $77M | Sell |
111,766
-47,013
| -30% | -$32.4M | 0.75% | 52 |
|
|
2022
Q2 | $93.9M | Buy |
158,779
+155,795
| +5,221% | +$92.1M | 0.92% | 43 |
|
|
2022
Q1 | $2.08M | Sell |
2,984
-2,262
| -43% | -$1.58M | 0.02% | 247 |
|
|
2021
Q4 | $3.31M | Buy |
+5,246
| New | +$3.31M | 0.03% | 188 |
|
|
2021
Q3 | – | Sell |
-508
| Closed | -$284K | – | 642 |
|
|
2021
Q2 | $284K | Buy |
+508
| New | +$284K | ﹤0.01% | 508 |
|
|
2020
Q4 | – | Sell |
-928
| Closed | -$519K | – | 547 |
|
|
2020
Q3 | $519K | Sell |
928
-1,606
| -63% | -$898K | 0.01% | 316 |
|
|
2020
Q2 | $1.58M | Sell |
2,534
-3,859
| -60% | -$2.41M | 0.02% | 199 |
|
|
2020
Q1 | $3.12M | Buy |
6,393
+2,788
| +77% | +$1.36M | 0.05% | 125 |
|
|
2019
Q4 | $1.35M | Buy |
3,605
+3,054
| +554% | +$1.15M | 0.02% | 234 |
|
|
2019
Q3 | $153K | Sell |
551
-3,422
| -86% | -$949K | ﹤0.01% | 420 |
|
|
2019
Q2 | $1.24M | Buy |
+3,973
| New | +$1.24M | 0.02% | 260 |
|
|
2018
Q2 | – | Sell |
-17,852
| Closed | -$6.15M | – | 482 |
|
|
2018
Q1 | $6.15M | Buy |
17,852
+8,396
| +89% | +$2.89M | 0.08% | 153 |
|
|
2017
Q4 | $3.56M | Buy |
9,456
+9,307
| +6,246% | +$3.5M | 0.05% | 179 |
|
|
2017
Q3 | $66.6K | Buy |
+149
| New | +$66.6K | ﹤0.01% | 437 |
|